Have your own idea? Try our Stock Screener
Finnish (OMX) Clinical Research and Equipment Industry Analysis
UpdatedJun 01, 2026
DataAggregated Company Financials
Companies1
- 7D18.7%
- 3M43.4%
- 1Y15.1%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has remained flat, although notably Nanoform Finland Oyj declined by 5.1%. Unfortunately though, the industry is down 9.1% over the past 12 months. As for the next few years, earnings are expected to grow by 50% per annum.
Industry Valuation and Performance
Has the Finnish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 01 Jun 2026 | €88.6m | €5.4m | -€15,967,000.00 | n/a | -5.5x | 16.3x |
| Wed, 29 Apr 2026 | €41.3m | €5.0m | -€17,898,000.00 | n/a | -2.3x | 8.2x |
| Fri, 27 Mar 2026 | €51.2m | €5.0m | -€17,898,000.00 | n/a | -2.9x | 10.2x |
| Sun, 22 Feb 2026 | €63.1m | €3.8m | -€21,772,927.00 | n/a | -2.9x | 16.4x |
| Tue, 20 Jan 2026 | €80.4m | €3.8m | -€21,772,927.00 | n/a | -3.7x | 20.9x |
| Thu, 18 Dec 2025 | €91.2m | €3.8m | -€21,772,927.00 | n/a | -4.2x | 23.7x |
| Sat, 15 Nov 2025 | €91.0m | €4.9m | -€21,773,927.00 | n/a | -4.2x | 18.6x |
| Mon, 13 Oct 2025 | €96.3m | €4.0m | -€22,541,927.00 | n/a | -4.3x | 24.4x |
| Wed, 10 Sep 2025 | €75.4m | €4.0m | -€22,541,927.00 | n/a | -3.3x | 19.1x |
| Fri, 08 Aug 2025 | €83.4m | €3.9m | -€21,820,927.00 | n/a | -3.8x | 21.2x |
| Sun, 06 Jul 2025 | €93.1m | €3.9m | -€21,820,927.00 | n/a | -4.3x | 23.6x |
| Tue, 03 Jun 2025 | €76.9m | €3.9m | -€21,820,927.00 | n/a | -3.5x | 19.5x |
| Thu, 01 May 2025 | €84.8m | €3.7m | -€23,427,927.00 | n/a | -3.6x | 23.2x |
| Sat, 29 Mar 2025 | €101.6m | €3.7m | -€23,427,927.00 | n/a | -4.3x | 27.7x |
| Mon, 24 Feb 2025 | €104.3m | €2.4m | -€23,073,874.00 | n/a | -4.5x | 43x |
| Wed, 22 Jan 2025 | €109.3m | €2.4m | -€23,073,874.00 | n/a | -4.7x | 45x |
| Fri, 20 Dec 2024 | €106.1m | €2.4m | -€23,073,874.00 | n/a | -4.6x | 43.7x |
| Sun, 17 Nov 2024 | €96.5m | €2.3m | -€21,666,874.00 | n/a | -4.5x | 42x |
| Tue, 15 Oct 2024 | €142.7m | €2.3m | -€21,666,874.00 | n/a | -6.6x | 62.2x |
| Thu, 12 Sep 2024 | €149.3m | €2.3m | -€21,666,874.00 | n/a | -6.9x | 65.1x |
| Sat, 10 Aug 2024 | €148.3m | €2.4m | -€23,231,874.00 | n/a | -6.4x | 61.2x |
| Mon, 08 Jul 2024 | €154.7m | €2.4m | -€23,231,874.00 | n/a | -6.7x | 63.8x |
| Wed, 05 Jun 2024 | €170.9m | €2.6m | -€20,755,874.00 | n/a | -8.2x | 66.6x |
| Fri, 03 May 2024 | €174.3m | €2.6m | -€20,755,874.00 | n/a | -8.4x | 67.9x |
| Sun, 31 Mar 2024 | €212.6m | €2.6m | -€20,755,874.00 | n/a | -10.2x | 82.8x |
| Tue, 27 Feb 2024 | €234.5m | €3.2m | -€20,985,848.00 | n/a | -11.2x | 74.4x |
| Thu, 25 Jan 2024 | €163.1m | €3.2m | -€20,985,848.00 | n/a | -7.8x | 51.8x |
| Sat, 23 Dec 2023 | €126.7m | €3.2m | -€20,985,848.00 | n/a | -6x | 40.2x |
| Mon, 20 Nov 2023 | €131.8m | €3.4m | -€22,017,848.00 | n/a | -6x | 39.2x |
| Wed, 18 Oct 2023 | €131.0m | €3.4m | -€22,017,848.00 | n/a | -5.9x | 39x |
| Fri, 15 Sep 2023 | €158.4m | €3.4m | -€22,017,848.00 | n/a | -7.2x | 47.1x |
| Sun, 13 Aug 2023 | €133.3m | €3.5m | -€21,271,848.00 | n/a | -6.3x | 38.4x |
| Tue, 11 Jul 2023 | €147.4m | €3.5m | -€21,271,848.00 | n/a | -6.9x | 42.5x |
| Thu, 08 Jun 2023 | €170.2m | €3.5m | -€21,271,848.00 | n/a | -8x | 49x |
Price to Earnings Ratio
-8x
Current Industry PE
- There is only one company in the Finnish Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have improved over the last three years.
- Revenues for these companies have grown 13% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Comparison
How does Finnish Clinical Research and Equipment compare with similar industries?
| FI Market | -0.76% | |
| Healthcare | -0.81% | |
| Life Sciences | 18.71% | |
| Clinical Research and Equipment | 18.71% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NANOFH Nanoform Finland Oyj | €1.03 | 13.6% +€10.6m | 15.0% | PS16.3x |